Monsanto’s smear merchant, the Genetic Literacy Project, is now Bayer’s bully
By Jonathan Matthews,
GMWatch
| 08. 31. 2022
Recently the Genetic Literacy Project has been heavily targeting critics of the herbicide Roundup, now owned by Bayer, with a barrage of articles, podcasts, and tweets, in which the controversial University of Florida scientist Kevin Folta has been much to the fore.
It all started when the Guardian published a piece by the award-winning journalist Carey Gillam on a CDC study showing the prevalence in urine samples in the US of Roundup’s controversial active ingredient glyphosate, which has been linked to cancer.
Kevin Folta led the charge for the GLP with a piece that labelled the Guardian article the latest example of “yellow journalism” (i.e. lurid, sensationalist reporting), not to mention “deceptive journalism”, by “scientifically illiterate journalists”. Folta then gave over a further three paragraphs to attacking Gillam personally and outlining his version of her “ethically questionable history”. This somehow failed to mention that, among other things, she won a Society of Environmental Journalists’ book award or that her former colleagues at Reuters say she is “an exceptional journalist” who produces “impeccably reported” stories.
“Slimeball tactics”
The GLP, which has...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...